Clinical trials
Atrial Fibrillation, Paroxysmal or Persistent clinical trials
Below are recruiting atrial fibrillation, paroxysmal or persistent clinical trials, each written for real people, not researchers. We’re tracking 475 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07510776Recruiting
Understanding long-term critical illness
This study looks closely at patients who stay in the ICU for 5 days or more to understand why some people recover more slowly. It may help doctors find better ways to support you during and after a long ICU stay.
Lisbon, Lisbon DistrictAges 18 years+ - NCT07532226Recruiting
Tracking how long patients stay on guselkumab for psoriatic arthritis
This study follows people with psoriatic arthritis (joint pain and swelling linked to psoriasis) who are starting a newer medication called guselkumab. Researchers want to learn how long patients continue taking this medicine and how well it works for them.
LilleAges 18 years+ - NCT07631221Recruiting
Protein Amount in Nutrition for Critically Ill Kidney Patients
This study tests whether different amounts of protein in tube feeding or IV nutrition affect kidney recovery in patients admitted to the intensive care unit (ICU) with kidney injury. The goal is to find the best protein level to help kidneys heal while patients are critically ill.
Buenos Aires, Buenos AiresAges 18 years+ - NCT07633730Recruiting
Nerve Block for Back Pain in Ankylosing Spondylitis
This study tests whether a nerve-blocking injection in the back muscles can relieve persistent back pain in people with ankylosing spondylitis (a condition causing spine inflammation and stiffness). The injection targets specific nerves to reduce pain while your current disease treatment continues.
Istanbul, PendikAges 18–65 - NCT07655479Recruiting
Switching to a stronger heart pump after heart attack
This trial tests whether switching to a more powerful heart pump (Impella 5.5) within 24 hours of a heart attack helps people whose hearts are still struggling despite a standard pump. It may be an option for patients who had a heart attack, received an Impella CP pump, but still need strong medication to keep blood flowing.
CologneAges 18–77 - NCT07661862Recruiting
Managing heart and lung symptoms after COVID-19
This trial tests a program to help people with ongoing fatigue, shortness of breath, or chest pain after COVID-19. It uses a personalized plan to improve your daily function and heart health.
Hobart, TasmaniaAges 40 years+ - NCT07456774Enrolling by invitation
How long do people stay on Ozempic for diabetes (China study)
This study looks at how well people in China stick with taking Ozempic (a once-weekly injection) compared to other diabetes medicines. It helps researchers understand if this medicine is easier to keep taking long-term.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07325682Enrolling by invitation
Testing for long-term viral infection in advanced cervical cancer
This study looks for lasting viral infection in women with advanced cervical cancer. The goal is to better understand how the virus behaves and may help choose future treatments.
TashkentAges 21–70 - NCT07144202Enrolling by invitation
Long-term protection study after EV71 vaccination
This study checks how long immunity lasts after receiving two doses of the EV71 vaccine. It is for children who took part in the earlier study and got either the vaccine or a placebo.
Guilin, GuangxiAges Any age - NCT07059819Enrolling by invitation
Local heat therapy for persistent high-risk HPV infection
This study tests whether local heat therapy can help clear a high-risk HPV infection that has lasted at least 3 months. It is for women who have no serious cervical cell changes or only mild changes (CIN) and who are generally healthy.
Shenyang, LiaoningAges 18–65 - NCT06999304Enrolling by invitation
Pilot TMS for ongoing mild concussion symptoms
This study tests whether a type of brain stimulation called TMS can help people with ongoing symptoms after a mild concussion. If you have had concussion symptoms for at least a month but less than a year, you may be able to join.
Saint Paul, MinnesotaAges 18–65 - NCT06985576Enrolling by invitation
Long-term safety follow-up for GF-CART01
This study is a long-term follow-up for people who have already received the GF-CART01 treatment in a previous study. It checks how safe the treatment stays over time and how long the effects last.
TaipeiAges Any age - NCT06926322Enrolling by invitation
Treating dead baby molars with special medicines
This study tests different medicines to treat dead (necrotic) baby molars in children. The goal is to safely clean the infection and save the tooth so it can stay until it falls out naturally.
CairoAges 4–8 - NCT06795763Enrolling by invitation
New imaging & catheter system for blocked heart arteries
This trial tests a new imaging and catheter system to treat chronic total blockages in heart arteries. If you still have chest pain or other symptoms despite medical therapy, this study may help open the blockage and improve blood flow.
Atlanta, GeorgiaAges 18 years+ - NCT06755515Enrolling by invitationPhase 2/Phase 3
Rulonilimab + Chemo for Advanced Cervical Cancer
This trial tests a new drug called Rulonilimab combined with chemotherapy, with or without bevacizumab, as the first treatment for cervical cancer that has spread or come back. It’s for people whose tumors have a specific marker (PD-L1) and who haven’t had other treatments for advanced disease.
Linyi, ShandongAges 18 years+ - NCT06618339Enrolling by invitation
Mindfulness training for young university students
This trial tests whether a mindfulness program can improve brain function and mental well-being in university students. It may help if you're interested in learning meditation techniques to support your mental health.
Mexicali, Estado de Baja CaliforniaAges 18–30 - NCT06484686Enrolling by invitationPhase 4
Long-term immunity study of chickenpox vaccine booster
This study follows up people who were in a previous phase 3 chickenpox vaccine trial. It checks how long protection from a booster dose lasts, by taking a blood sample.
Zhengzhou, HenanAges 8–16 - NCT05941559Enrolling by invitation
EMDR therapy for long-term rheumatoid arthritis pain
This trial tests whether eye-movement therapy (EMDR) can reduce long-lasting pain in people with rheumatoid arthritis (RA). You may be eligible if your RA has been relatively stable, your pain is still high, and you can take part in therapy sessions safely.
Enschede, OverijsselAges 18 years+ - NCT05095701Enrolling by invitationPhase 4
Study tracks lasting protection from a live chickenpox vaccine
This trial follows people who previously took a chickenpox (varicella) vaccine to see how long their immune protection lasts. It may help explain who stays protected over time and for how long.
Xuchang, HenanAges 1–17
Hear when a new Atrial Fibrillation, Paroxysmal or Persistent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for atrial fibrillation, paroxysmal or persistent?
- Yes. Clin2 currently lists 475 recruiting atrial fibrillation, paroxysmal or persistent studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a atrial fibrillation, paroxysmal or persistent trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a atrial fibrillation, paroxysmal or persistent trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.